Phreesia (NYSE:PHR) Stock Bumped Up to “Buy” by Wall Street Zen

Wall Street Zen upgraded shares of Phreesia (NYSE:PHR) from a hold rating to a buy rating in a research note issued to investors on Saturday morning,Wall Street Zen reports.

PHR has been the subject of a number of other reports. Robert W. Baird increased their target price on shares of Phreesia from $10.00 to $11.00 and gave the company a “neutral” rating in a research report on Friday, September 4th. Raymond James Financial lowered shares of Phreesia from an “outperform” rating to a “market perform” rating in a research report on Tuesday, September 8th. Needham & Company LLC reaffirmed a “buy” rating and set a $14.00 price objective on shares of Phreesia in a research note on Monday, August 31st. Citigroup reiterated a “market perform” rating on shares of Phreesia in a report on Friday, September 4th. Finally, Weiss Ratings lowered shares of Phreesia from a “sell (d+)” rating to a “sell (d)” rating in a research note on Friday, September 4th. Eight equities research analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat.com, Phreesia has a consensus rating of “Hold” and a consensus price target of $14.00.

Phreesia Stock Up 1.2%

Shares of PHR opened at $10.79 on Friday. The company has a debt-to-equity ratio of 0.33, a quick ratio of 1.76 and a current ratio of 1.76. Phreesia has a one year low of $7.77 and a one year high of $24.13. The stock has a market capitalization of $669.67 million, a price-to-earnings ratio of 63.47 and a beta of 0.84. The stock has a 50 day moving average price of $11.06 and a 200 day moving average price of $10.20.

Phreesia (NYSE:PHR) last posted its quarterly earnings data on Wednesday, September 2nd. The company reported $0.03 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.06). Phreesia had a net margin of 2.06% and a return on equity of 5.22%. The firm had revenue of $129.46 million during the quarter, compared to analyst estimates of $129.06 million. During the same period in the prior year, the company posted $0.01 earnings per share. The firm’s revenue for the quarter was up 10.4% compared to the same quarter last year. Equities research analysts forecast that Phreesia will post 0.33 earnings per share for the current fiscal year.

Insider Activity at Phreesia

In related news, General Counsel Allison C. Hoffman sold 6,662 shares of the stock in a transaction dated Monday, September 21st. The stock was sold at an average price of $10.08, for a total transaction of $67,152.96. Following the transaction, the general counsel owned 266,574 shares of the company’s stock, valued at approximately $2,687,065.92. This represents a 2.44% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. 5.20% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On Phreesia

A number of large investors have recently modified their holdings of PHR. Rockefeller Capital Management L.P. boosted its stake in Phreesia by 354.6% in the 4th quarter. Rockefeller Capital Management L.P. now owns 2,755 shares of the company’s stock worth $47,000 after buying an additional 2,149 shares during the last quarter. Allworth Financial LP increased its stake in shares of Phreesia by 78.3% during the 2nd quarter. Allworth Financial LP now owns 5,613 shares of the company’s stock valued at $58,000 after acquiring an additional 2,465 shares during the last quarter. Diversified Trust Co increased its stake in shares of Phreesia by 5.8% during the 1st quarter. Diversified Trust Co now owns 54,418 shares of the company’s stock valued at $456,000 after acquiring an additional 2,996 shares during the last quarter. EverSource Wealth Advisors LLC lifted its holdings in shares of Phreesia by 1,119.8% during the 1st quarter. EverSource Wealth Advisors LLC now owns 3,269 shares of the company’s stock worth $27,000 after acquiring an additional 3,001 shares during the period. Finally, Integrated Wealth Concepts LLC boosted its position in shares of Phreesia by 37.2% in the second quarter. Integrated Wealth Concepts LLC now owns 14,129 shares of the company’s stock worth $145,000 after acquiring an additional 3,834 shares during the last quarter. 92.10% of the stock is owned by hedge funds and other institutional investors.

Phreesia Company Profile

Phreesia, Inc is a healthcare technology company that provides software and services designed to simplify and automate the patient intake process. Its platform helps healthcare organizations manage registration, consent forms, clinical questionnaires, insurance and demographic information, payments, and other administrative tasks through digital tools.

The company’s offerings are used by medical practices, health systems, and other healthcare organizations to improve patient engagement and support administrative and revenue-cycle workflows.